Evidence map›Paper›PMID 37081955›Full record

ArticleFrontiers in public health2023

Corrigendum: Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020-2021: Impact on medication adherence.

Mengxian Zhang, Guiyang Wang, Hina Najmi, Aashifa Yaqoob, Tao Li, Yinyin Xia, Jianjun Ye, Shuangyi Hou, Ye Xiao, Liping Zhou and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Mengxian ZhangInstitute for Tuberculosis Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China.
Guiyang WangWuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control, Wuhan, Hubei, China.
Hina NajmiHealth Services Academy, Islamabad, Pakistan.
Aashifa YaqoobCommon Management Unit (TB, HIV/AIDS & Malaria), Islamabad, Pakistan.
Tao LiNational Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yinyin XiaNational Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jianjun YeInstitute for Tuberculosis Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China.
Shuangyi HouInstitute for Tuberculosis Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China.
Ye XiaoBeijing SINOVO Power Technology LTD., Beijing, China.
Liping ZhouInstitute for Tuberculosis Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China.
Yuehua LiWuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control, Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fpubh.2023.1033532.].

Indexed as

Chinadigital adherence technologymedication adherence and treatment outcomeoperational researchtuberculosis

Identifiers

PMID37081955
PMCPMC10111818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.